-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Champions Oncology, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Champions Oncology, Inc. Income Tax Expense (Benefit) for the quarter ending July 31, 2024 was $21K, a 25% decline year-over-year.
- Champions Oncology, Inc. Income Tax Expense (Benefit) for the twelve months ending July 31, 2024 was -$39K, a 149% decline year-over-year.
- Champions Oncology, Inc. annual Income Tax Expense (Benefit) for 2023 was -$32K, a 147% decline from 2022.
- Champions Oncology, Inc. annual Income Tax Expense (Benefit) for 2022 was $68K, a 94.3% increase from 2021.
- Champions Oncology, Inc. annual Income Tax Expense (Benefit) for 2021 was $35K, a 53.3% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)